Suppr超能文献

螺旋断层放疗治疗伴有淋巴结转移的乳腺癌的表面成像、激光定位或容积成像。

Surface imaging, laser positioning or volumetric imaging for breast cancer with nodal involvement treated by helical TomoTherapy.

机构信息

Centre Oscar Lambret and Université Lille.

出版信息

J Appl Clin Med Phys. 2016 Sep 8;17(5):200-211. doi: 10.1120/jacmp.v17i5.6041.

Abstract

A surface imaging system, Catalyst (C-Rad), was compared with laser-based positioning and daily mega voltage computed tomography (MVCT) setup for breast patients with nodal involvement treated by helical TomoTherapy. Catalyst-based positioning performed better than laser-based positioning. The respective modalities resulted in a standard deviation (SD), 68% confidence interval (CI) of positioning of left-right, craniocaudal, anterior-posterior, roll: 2.4 mm, 2.7 mm, 2.4 mm, 0.9° for Catalyst positioning, and 6.1 mm, 3.8 mm, 4.9 mm, 1.1° for laser-based positioning, respectively. MVCT-based precision is a combination of the interoperator variability for MVCT fusion and the patient movement during the time it takes for MVCT and fusion. The MVCT fusion interoperator variability for breast patients was evaluated at one SD left-right, craniocaudal, ant-post, roll as: 1.4 mm, 1.8 mm, 1.3 mm, 1.0°. There was no statistically significant difference between the automatic MVCT registration result and the manual adjustment; the automatic fusion results were within the 95% CI of the mean result of 10 users, except for one specific case where the patient was positioned with large yaw. We found that users add variability to the roll correction as the automatic registration was more consistent. The patient position uncertainty confidence interval was evaluated as 1.9 mm, 2.2 mm, 1.6 mm, 0.9° after 4 min, and 2.3 mm, 2.8 mm, 2.2 mm, 1° after 10 min. The combination of this patient movement with MVCT fusion interoperator variability results in total standard deviations of patient posi-tion when treatment starts 4 or 10 min after initial positioning of, respectively: 2.3 mm, 2.8 mm, 2.0 mm, 1.3° and 2.7 mm, 3.3 mm, 2.6 mm, 1.4°. Surface based positioning arrives at the same precision when taking into account the time required for MVCT imaging and fusion. These results can be used on a patient-per-patient basis to decide which positioning system performs the best after the first 5 fractions and when daily MVCT can be omitted. Ideally, real-time monitoring is required to reduce important intrafraction movement.

摘要

一种表面成像系统 Catalyst(C-Rad)与基于激光的定位和每日兆伏 CT(MVCT)对接受螺旋断层放疗的有淋巴结受累的乳腺癌患者的设置进行了比较。基于 Catalyst 的定位优于基于激光的定位。两种方法的定位标准偏差(SD)、左-右、颅-尾、前-后、旋转分别为:68%置信区间(CI)为 2.4mm、2.7mm、2.4mm、0.9°,对于 Catalyst 定位,分别为 6.1mm、3.8mm、4.9mm、1.1°,用于基于激光的定位。MVCT 基于精度是 MVCT 融合和 MVCT 融合期间患者运动的操作员间变异性的组合。评估了乳腺癌患者的 MVCT 融合操作员间变异性,在 1 SD 左-右、颅-尾、前-后、旋转为:1.4mm、1.8mm、1.3mm、1.0°。自动 MVCT 注册结果与手动调整之间无统计学差异;自动融合结果在 10 位用户平均结果的 95%置信区间内,除了一个特定病例,患者的定位存在大的偏航。我们发现,随着自动注册的一致性提高,用户增加了旋转校正的变异性。在初始定位后 4 分钟和 10 分钟后,患者位置不确定性置信区间分别为 1.9mm、2.2mm、1.6mm、0.9°和 2.3mm、2.8mm、2.2mm、1°。将患者运动与 MVCT 融合操作员间变异性相结合,在初始定位后 4 或 10 分钟开始治疗时,患者位置的总标准偏差分别为:2.3mm、2.8mm、2.0mm、1.3°和 2.7mm、3.3mm、2.6mm、1.4°。考虑到 MVCT 成像和融合所需的时间,基于表面的定位可达到相同的精度。可以在患者个体的基础上使用这些结果来决定在前 5 个分数后哪种定位系统表现最好,以及何时可以省略每日 MVCT。理想情况下,需要实时监测以减少重要的分次内运动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ca/5874112/0132c8965f9e/ACM2-17-200-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验